A Molecular Anatomic Imaging Analysis of Tau in Progressive Supranuclear Palsy
NCT02605785
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
This study is designed to learn more about overall tau burden in the brain of patients with Progressive Supranuclear Palsy (PSP).
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Progressive Supranuclear Palsy
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 35 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- Mayo Clinic
- Last updated on ClinicalTrials.gov
- May 5, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Minnesota · 1
- Mayo Clinic · Rochester, MN
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.